Clinical Trials Browser

Sulindac × Gastrointestinal × 30 days × Clear all

NCT04207944 2026-06-04

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Intraductal Neoplasms